Rather than advocating for SNHG1 as a standalone biomarker for HCC management, this review aims to describe the scope of SNHG1’s involvement in HCC and highlight its potential as an additional serum marker to improve detection rates and prognosis prediction. The gene discussed is SNHG1; the disease is hepatocellular carcinoma.